Proceedings of the fourth international conference on central hypoventilation

Ha Trang, Jean François Brunet, Hermann Rohrer, Jorge Gallego, Jeanne Amiel, Tiziana Bachetti, Kenneth H. Fischbeck, Thomas Similowski, Christian Straus, Isabella Ceccherini, Debra E. Weese-Mayer, Matthias Frerick, Katarzyna Bieganowska, Linda Middleton, Francesco Morandi, Giancarlo Ottonello

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Central hypoventilation syndromes (CHS) are rare diseases of central autonomic respiratory control associated with autonomous nervous dysfunction. Severe central hypoventilation is the hallmark and the most life-threatening feature. CHS is a group of not-fully defined disorders. Congenital CHS (CCHS) (ORPHA661) is clinically and genetically well-characterized, with the disease-causing gene identified in 2003. CCHS presents at birth in most cases, and associated with Hirschsprung's disease (ORPHA99803) and neural crest tumours in 20% and 5% of cases, respectively. The incidence of CCHS is estimated to be 1 of 200,000 live births in France, yet remains unknown for the rest of the world. In contrast, late-onset CHS includes a group of not yet fully delineated diseases. Overlap with CCHS is likely, as a subset of patients harbours PHOX2B mutations. Another subset of patients present with associated hypothalamic dysfunction. The number of these patients is unknown (less than 60 cases reported worldwide). Treatment of CHS is palliative using advanced techniques of ventilation support during lifetime. Research is ongoing to better understand physiopathological mechanisms and identify potential treatment pathways.The Fourth International Conference on Central Hypoventilation was organised in Warsaw, Poland, April 13-15, 2012, under the patronage of the European Agency for Health and Consumers and Public Health European Agency of European Community. The conference provided a state-of-the-art update of knowledge on all the genetic, molecular, cellular, and clinical aspects of these rare diseases.

Original languageEnglish
Pages (from-to)194
Number of pages1
JournalOrphanet Journal of Rare Diseases
Volume9
DOIs
Publication statusPublished - 2014

Fingerprint

Hypoventilation
Rare Diseases
Hirschsprung Disease
Live Birth
European Union
Poland
France
Ventilation
Molecular Biology
Public Health
Parturition
Mutation
Incidence
Health
Therapeutics
Research
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Trang, H., Brunet, J. F., Rohrer, H., Gallego, J., Amiel, J., Bachetti, T., ... Ottonello, G. (2014). Proceedings of the fourth international conference on central hypoventilation. Orphanet Journal of Rare Diseases, 9, 194. https://doi.org/10.1186/s13023-014-0194-5

Proceedings of the fourth international conference on central hypoventilation. / Trang, Ha; Brunet, Jean François; Rohrer, Hermann; Gallego, Jorge; Amiel, Jeanne; Bachetti, Tiziana; Fischbeck, Kenneth H.; Similowski, Thomas; Straus, Christian; Ceccherini, Isabella; Weese-Mayer, Debra E.; Frerick, Matthias; Bieganowska, Katarzyna; Middleton, Linda; Morandi, Francesco; Ottonello, Giancarlo.

In: Orphanet Journal of Rare Diseases, Vol. 9, 2014, p. 194.

Research output: Contribution to journalArticle

Trang, H, Brunet, JF, Rohrer, H, Gallego, J, Amiel, J, Bachetti, T, Fischbeck, KH, Similowski, T, Straus, C, Ceccherini, I, Weese-Mayer, DE, Frerick, M, Bieganowska, K, Middleton, L, Morandi, F & Ottonello, G 2014, 'Proceedings of the fourth international conference on central hypoventilation', Orphanet Journal of Rare Diseases, vol. 9, pp. 194. https://doi.org/10.1186/s13023-014-0194-5
Trang, Ha ; Brunet, Jean François ; Rohrer, Hermann ; Gallego, Jorge ; Amiel, Jeanne ; Bachetti, Tiziana ; Fischbeck, Kenneth H. ; Similowski, Thomas ; Straus, Christian ; Ceccherini, Isabella ; Weese-Mayer, Debra E. ; Frerick, Matthias ; Bieganowska, Katarzyna ; Middleton, Linda ; Morandi, Francesco ; Ottonello, Giancarlo. / Proceedings of the fourth international conference on central hypoventilation. In: Orphanet Journal of Rare Diseases. 2014 ; Vol. 9. pp. 194.
@article{0209797c72904fb58f214a96b312b47a,
title = "Proceedings of the fourth international conference on central hypoventilation",
abstract = "Central hypoventilation syndromes (CHS) are rare diseases of central autonomic respiratory control associated with autonomous nervous dysfunction. Severe central hypoventilation is the hallmark and the most life-threatening feature. CHS is a group of not-fully defined disorders. Congenital CHS (CCHS) (ORPHA661) is clinically and genetically well-characterized, with the disease-causing gene identified in 2003. CCHS presents at birth in most cases, and associated with Hirschsprung's disease (ORPHA99803) and neural crest tumours in 20{\%} and 5{\%} of cases, respectively. The incidence of CCHS is estimated to be 1 of 200,000 live births in France, yet remains unknown for the rest of the world. In contrast, late-onset CHS includes a group of not yet fully delineated diseases. Overlap with CCHS is likely, as a subset of patients harbours PHOX2B mutations. Another subset of patients present with associated hypothalamic dysfunction. The number of these patients is unknown (less than 60 cases reported worldwide). Treatment of CHS is palliative using advanced techniques of ventilation support during lifetime. Research is ongoing to better understand physiopathological mechanisms and identify potential treatment pathways.The Fourth International Conference on Central Hypoventilation was organised in Warsaw, Poland, April 13-15, 2012, under the patronage of the European Agency for Health and Consumers and Public Health European Agency of European Community. The conference provided a state-of-the-art update of knowledge on all the genetic, molecular, cellular, and clinical aspects of these rare diseases.",
author = "Ha Trang and Brunet, {Jean Fran{\cc}ois} and Hermann Rohrer and Jorge Gallego and Jeanne Amiel and Tiziana Bachetti and Fischbeck, {Kenneth H.} and Thomas Similowski and Christian Straus and Isabella Ceccherini and Weese-Mayer, {Debra E.} and Matthias Frerick and Katarzyna Bieganowska and Linda Middleton and Francesco Morandi and Giancarlo Ottonello",
year = "2014",
doi = "10.1186/s13023-014-0194-5",
language = "English",
volume = "9",
pages = "194",
journal = "Orphanet Journal of Rare Diseases",
issn = "1750-1172",
publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Proceedings of the fourth international conference on central hypoventilation

AU - Trang, Ha

AU - Brunet, Jean François

AU - Rohrer, Hermann

AU - Gallego, Jorge

AU - Amiel, Jeanne

AU - Bachetti, Tiziana

AU - Fischbeck, Kenneth H.

AU - Similowski, Thomas

AU - Straus, Christian

AU - Ceccherini, Isabella

AU - Weese-Mayer, Debra E.

AU - Frerick, Matthias

AU - Bieganowska, Katarzyna

AU - Middleton, Linda

AU - Morandi, Francesco

AU - Ottonello, Giancarlo

PY - 2014

Y1 - 2014

N2 - Central hypoventilation syndromes (CHS) are rare diseases of central autonomic respiratory control associated with autonomous nervous dysfunction. Severe central hypoventilation is the hallmark and the most life-threatening feature. CHS is a group of not-fully defined disorders. Congenital CHS (CCHS) (ORPHA661) is clinically and genetically well-characterized, with the disease-causing gene identified in 2003. CCHS presents at birth in most cases, and associated with Hirschsprung's disease (ORPHA99803) and neural crest tumours in 20% and 5% of cases, respectively. The incidence of CCHS is estimated to be 1 of 200,000 live births in France, yet remains unknown for the rest of the world. In contrast, late-onset CHS includes a group of not yet fully delineated diseases. Overlap with CCHS is likely, as a subset of patients harbours PHOX2B mutations. Another subset of patients present with associated hypothalamic dysfunction. The number of these patients is unknown (less than 60 cases reported worldwide). Treatment of CHS is palliative using advanced techniques of ventilation support during lifetime. Research is ongoing to better understand physiopathological mechanisms and identify potential treatment pathways.The Fourth International Conference on Central Hypoventilation was organised in Warsaw, Poland, April 13-15, 2012, under the patronage of the European Agency for Health and Consumers and Public Health European Agency of European Community. The conference provided a state-of-the-art update of knowledge on all the genetic, molecular, cellular, and clinical aspects of these rare diseases.

AB - Central hypoventilation syndromes (CHS) are rare diseases of central autonomic respiratory control associated with autonomous nervous dysfunction. Severe central hypoventilation is the hallmark and the most life-threatening feature. CHS is a group of not-fully defined disorders. Congenital CHS (CCHS) (ORPHA661) is clinically and genetically well-characterized, with the disease-causing gene identified in 2003. CCHS presents at birth in most cases, and associated with Hirschsprung's disease (ORPHA99803) and neural crest tumours in 20% and 5% of cases, respectively. The incidence of CCHS is estimated to be 1 of 200,000 live births in France, yet remains unknown for the rest of the world. In contrast, late-onset CHS includes a group of not yet fully delineated diseases. Overlap with CCHS is likely, as a subset of patients harbours PHOX2B mutations. Another subset of patients present with associated hypothalamic dysfunction. The number of these patients is unknown (less than 60 cases reported worldwide). Treatment of CHS is palliative using advanced techniques of ventilation support during lifetime. Research is ongoing to better understand physiopathological mechanisms and identify potential treatment pathways.The Fourth International Conference on Central Hypoventilation was organised in Warsaw, Poland, April 13-15, 2012, under the patronage of the European Agency for Health and Consumers and Public Health European Agency of European Community. The conference provided a state-of-the-art update of knowledge on all the genetic, molecular, cellular, and clinical aspects of these rare diseases.

UR - http://www.scopus.com/inward/record.url?scp=84964315048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964315048&partnerID=8YFLogxK

U2 - 10.1186/s13023-014-0194-5

DO - 10.1186/s13023-014-0194-5

M3 - Article

C2 - 25928806

AN - SCOPUS:84964315048

VL - 9

SP - 194

JO - Orphanet Journal of Rare Diseases

JF - Orphanet Journal of Rare Diseases

SN - 1750-1172

ER -